William Gartland, Ph.D. 
January 28, 1982 
- 2 - 
It is our committee's opinion that a relaxation such as the ones 
being proposed will create many problems. Such a change could have 
a significantly detrimental effect on recombinant DNA research and 
development activities in Massachusetts. We urge a more conserva- 
tive approach at this time. 
Sincerely yours. 
lomas O'Brien, M.D. 
Chairman 
Committee on the Regulation of 
Hazardous Biological Agents - 
Harvard Medical Area 
[ 712 ] 
